GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1 ; volume:21 ; number:1 ; day:3 ; month:8 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (3.8.2023), 1-14, 12.2023
- Urheber
-
Tang, Yu
Dai, Gaosai
Yang, Yupeng
Liu, Huantao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04358-2
- URN
-
urn:nbn:de:101:1-2023110109461918612372
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Yu
- Dai, Gaosai
- Yang, Yupeng
- Liu, Huantao
- SpringerLink (Online service)
Ähnliche Objekte (12)
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression
Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
Correction: TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway
The ambivalent nature of E2F1 in drug induced cell death and tumor progression
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression
MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression
Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
Correction: TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway
The ambivalent nature of E2F1 in drug induced cell death and tumor progression
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression
MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation
TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression
Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation
TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
Correction: TNKS1BP1 facilitates ubiquitination of CNOT4 by TRIM21 to promote hepatocellular carcinoma progression and immune evasion
CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway
The ambivalent nature of E2F1 in drug induced cell death and tumor progression
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression